ALSO NOTED: Genta places notes;Vaccine research blasts off; and much more...

> Genta announced that it has struck definitive agreements with investors to place senior secured convertible notes due in 2010 totaling in aggregate up to $40 million in gross proceeds before fees and expenses. Release

> A Lehman Brothers analyst is bullish on Regeneron's cancer drug aflibercept, saying it compares well to Avastin. That opinion came after investors shaved 20 percent off the value of Regeneron shares after seeing disappointing data for ovarian cancer. Report

> The biotech start-up Iatrica is moving into new space at the John G. Rangos Building in East Baltimore. The building opened in April. Story

> Sangamo BioSciences has completed patient enrollment into its Phase II clinical trial in subjects with moderate to severe diabetic neuropathy. Release

> Topical applications of a naturally occurring fat molecule have the potential to slow down skin aging, whether through natural causes or damage, researchers report. Release

And Finally... Vaccine research is heading to outer space. Report

Suggested Articles

NASH leaders weigh in on the need for a drug for the disease and the challenges in getting it to patients.

The $210 million fund began life by leading a $17 million series A round in Quellis Biosciences.

The nine-story building will house Amgen’s Bay Area employees when it opens early in 2022.